Nathalie Fégueux

Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study

Élie Azoulay, Pedro Castro, Adel Maamar et al. · The Lancet Haematology · 2021 · 91 citations

Clinical Immunology, Translational Medicine, Cell Therapy +8

Pharmacokinetic variability of voriconazole and N-oxide voriconazole measured as therapeutic drug monitoring

Céline Eiden, M. Cociglio, Dominique Hillaire‐Buys et al. · Xenobiotica · 2010 · 26 citations

Vrc Plasma Concentrations, Pharmacotherapy, Medicinal Chemistry +17

Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party

Olaf Penack, Christophe Peczynski, Christian Koenecke et al. · Journal for ImmunoTherapy of Cancer · 2023 · 24 citations · Full text

Cell Therapy, Ctcae Cytopenia, Immunodeficiencies +22

CD23 Antigen Density is Related to Serum Gamma Globulin Level, Bone Marrow Reticulin Pattern, and Treatment in B Chronic Lymphocytic Leukemia

Thierry Lavabre‐Bertrand, C Exbrayat, Pascal Bourquard et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1994 · 20 citations

Immunohematology, Immunology, Blood Cell +16

Outcomes of unrelated cord blood transplantation in patients with multiple myeloma: a survey on behalf of Eurocord, the Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, and the Chronic Leukemia Working Party of the EBMT

Annalisa Paviglianiti, E. G. Xavier, Annalisa Ruggeri et al. · Haematologica · 2016 · 20 citations · Full text

Cell Therapy, Mixed-phenotype Acute Leukemia, Immunology +18